Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma.
Hong R, Tan Su Yin E, Wang L, Zhao X, Zhou L, Wang G, Zhang M, Zhao H, Wei G, Wang Y, Wu W, Zhang Y, Ni F, Hu Y, Huang H, Zhao K.
Hong R, et al. Among authors: wang g, wang l, wang y.
Front Oncol. 2021 Aug 4;11:713577. doi: 10.3389/fonc.2021.713577. eCollection 2021.
Front Oncol. 2021.
PMID: 34422666
Free PMC article.